Evidence map›Paper›PMID 39483612›Full record

ReviewClimate policy2024

Health co-benefits and trade-offs of carbon pricing: a narrative synthesis.

Soledad Cuevas, Daniel Nachtigall, Aimee Aguilar Jaber, Kristine Belesova, Jane Falconer, Andy Haines, Tamzin Reynolds, Tobias Magnus Schuster, Sarah Whitmee, Rosemary Green

Abstract readReview
In one paragraph

Review in Climate policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Soledad CuevasLondon School of Hygiene and Tropical Medicine, London, UK.
Daniel NachtigallOECD, Paris, France.
Aimee Aguilar JaberOECD, Paris, France.
Kristine BelesovaLondon School of Hygiene and Tropical Medicine, London, UK.
Jane FalconerLondon School of Hygiene and Tropical Medicine, London, UK.
Andy HainesLondon School of Hygiene and Tropical Medicine, London, UK.
Tamzin ReynoldsLondon School of Hygiene and Tropical Medicine, London, UK.
Tobias Magnus SchusterLondon School of Hygiene and Tropical Medicine, London, UK.
Sarah WhitmeeLondon School of Hygiene and Tropical Medicine, London, UK.
Rosemary GreenLondon School of Hygiene and Tropical Medicine, London, UK.

Funding

Wellcome Trust 227165
6 · The paper itself

Abstract

Carbon pricing is a key component of current climate policy agendas. There are a variety of societal and health impacts from carbon pricing interventions (e.g. from improved air quality). A better understanding of potential health impacts and how they depend on context and policy design is crucial to improve the political feasibility and fairness of carbon pricing. Recent reviews have synthesized evidence on the effectiveness, equity and perceptions of carbon pricing and on the health co-benefits of mitigation. This review provides a narrative structured synthesis of the health impacts of carbon pricing. We identified 58 relevant publications of which all were modelling studies. We classify review findings into policy-relevant categories, synthesizing information on how carbon pricing affects health outcomes when implemented in different contexts, in isolation or as part of policy mixes. Findings suggest that internalization of health co-benefits in optimal price level estimates could lead to substantial mitigation in some regions. There are also opportunities to design carbon pricing to improve health outcomes, including through progressive or targeted use of revenues to improve food security, subsidize healthier diets or promote active transportation. Revenue use, price differentiation, market size and permit allocation of emissions trading schemes (ETS), and interaction with other public health or mitigation policies all influence health outcomes. Overall, the health impacts of carbon pricing are highly context-specific and further evidence is needed, particularly on health inequalities and ex-post analysis. However, existing evidence suggests that it is possible to design health-beneficial carbon pricing policies, thus enhancing policy acceptability and feasibility.

Indexed as

Carbon pricingevidence synthesishealth co-benefitsmitigationpolicy analysis

Identifiers

PMID39483612
PMCPMC11523918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.